Official websites use. Share sensitive information only on official, secure websites. Email: nogu umn. Primary objective: determine the outcomes of AS local treatment at the referral dermatology service of the authors' institution. Secondary objective: determine signalment, body condition score BCS , stool quality and comorbidities associated with AS. An electronic medical record search was conducted. Information regarding sex, breed, age at disease onset, weight, BCS, stool quality, comorbidities, treatment and treatment outcome were collected.
Dogs were excluded if seen by another service, not treated for AS, or if perianal sinuses fistulae , anal sac masses, or anal sac abscesses were identified. Nineteen dogs were male and 14 female. Average age at disease onset was 4. Average BCS was 5. Atopic dermatitis was the most common comorbidity 12 of Treatment was repeated on average 2. Resolution of AS was obtained in 24 of 33 cases, clinical signs resolved per owner in four of 33, five of 33 cases did not complete treatment, and no cases failed treatment.
Background β Little information has been published regarding treatment of canine anal sacculitis AS. Objectives β Primary objective: determine the outcomes of AS local treatment at the referral dermatology service of the authors' institution. Secondary objective: determine signalment, body condition score, stool quality and comorbidities associated with AS.
Conclusions and clinical relevance β Local treatment with flushing and infusion is effective for treating AS in dogs. Se incluyeron veinticuatro razas.
BCS promedio fue 5. La calidad de las heces fue "mala" en siete de 33 y normal en 23 de 33 casos. Hunde, die von einem anderen Service untersucht wurden, die nicht auf AS behandelt wurden, oder wenn perianale Fisteln Fistulae , Analbeutelmassen oder β abszesse auftraten, wurden ausgeschlossen.
